GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Y.S.P. Southeast Asia Holding Bhd (XKLS:7178) » Definitions » Revenue

Y.S.P. Southeast Asia Holding Bhd (XKLS:7178) Revenue : RM355.0 Mil (TTM As of Dec. 2023)


View and export this data going back to 2004. Start your Free Trial

What is Y.S.P. Southeast Asia Holding Bhd Revenue?

Y.S.P. Southeast Asia Holding Bhd's revenue for the three months ended in Dec. 2023 was RM89.3 Mil. Its revenue for the trailing twelve months (TTM) ended in Dec. 2023 was RM355.0 Mil. Y.S.P. Southeast Asia Holding Bhd's Revenue per Share for the three months ended in Dec. 2023 was RM0.63. Its Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was RM2.50.

Good Sign:

Y.S.P. Southeast Asia Holding Bhd has shown predictable revenue and earnings growth.

During the past 12 months, the average Revenue per Share Growth Rate of Y.S.P. Southeast Asia Holding Bhd was 6.00% per year. During the past 3 years, the average Revenue per Share Growth Rate was 5.90% per year. During the past 5 years, the average Revenue per Share Growth Rate was 3.50% per year. During the past 10 years, the average Revenue per Share Growth Rate was 5.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate using Revenue per Share data.

During the past 13 years, Y.S.P. Southeast Asia Holding Bhd's highest 3-Year average Revenue per Share Growth Rate was 8.70% per year. The lowest was -13.20% per year. And the median was 3.80% per year.


Y.S.P. Southeast Asia Holding Bhd Revenue Historical Data

The historical data trend for Y.S.P. Southeast Asia Holding Bhd's Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Y.S.P. Southeast Asia Holding Bhd Revenue Chart

Y.S.P. Southeast Asia Holding Bhd Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 295.62 297.06 281.86 334.25 355.00

Y.S.P. Southeast Asia Holding Bhd Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 82.55 95.59 79.63 90.45 89.33

Competitive Comparison of Y.S.P. Southeast Asia Holding Bhd's Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, Y.S.P. Southeast Asia Holding Bhd's Revenue, along with its competitors' market caps and Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Y.S.P. Southeast Asia Holding Bhd's Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Y.S.P. Southeast Asia Holding Bhd's Revenue distribution charts can be found below:

* The bar in red indicates where Y.S.P. Southeast Asia Holding Bhd's Revenue falls into.



Y.S.P. Southeast Asia Holding Bhd Revenue Calculation

Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.

Revenue for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was RM355.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Y.S.P. Southeast Asia Holding Bhd  (XKLS:7178) Revenue Explanation

In ranking the predictability, companies with more consistent revenue and earnings growth are ranked high with predictability.

Peter Lynch categorized companies according to their revenue growth:


Slow Grower: Inflation < 10-Year Revenue Growth Rate < 10%:
Stalwart: 10% < 10-Year Revenue Growth Rate < 20%:
Fast Grower: 10-Year Revenue Growth Rate > 20%:

His favorite companies are stalwart, those growing between 10-20% a year.

Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.


Be Aware

Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.


Y.S.P. Southeast Asia Holding Bhd Revenue Related Terms

Thank you for viewing the detailed overview of Y.S.P. Southeast Asia Holding Bhd's Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Y.S.P. Southeast Asia Holding Bhd (XKLS:7178) Business Description

Traded in Other Exchanges
N/A
Address
Number 1, Jalan Wan Kadir, Level 22, Menara LGB, Taman Tun Dr. Ismail, Kuala Lumpur, MYS, 60000
Y.S.P. Southeast Asia Holding Bhd is an investment company, which engages in the pharmaceutical business, and provision of management services. It operates through the following segments: Trading, Manufacturing, and Investment Holding. The Trading segment imports, exports, and trades various kinds of pharmaceutical products, and traditional herbal and veterinary products. The Manufacturing segment manufactures pharmaceutical products. The Investment Holding segment focuses on investment holding activity. The firm's majority of revenue comes from the Manufacturing segment. The majority of revenue is concentrated in Malaysia.

Y.S.P. Southeast Asia Holding Bhd (XKLS:7178) Headlines

No Headlines